Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?

Cardiovascular Diabetology

Coert J. Zuurbier¹ 

[1]Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

关键词: SGLT2i;    Hyperglycemia;    Xylazine;    Infarct size;    Ischemia-reperfusion;   

DOI  :  10.1186/s12933-020-01119-z

来源: Springer

【 授权许可】

CC BY